ARCHIVES

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

This article is from The Cancer Letter archive.

Vol. 26 No. 19 | May 12, 2000

Download PDF Visit The Full Archive

Related Articles

Colon Cancer Screening Interval 5-10 Years Suggested

September 26, 2008

Tafinlar Subgroup Data Shows Median OS of 20 Months

October 31, 2014

Intramural Pis To Control Own Budgets, Have Greater Autonomy, Klausner Says

December 15, 1995

Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting

June 20, 1986

NCI Advisory Group, Other Cancer Meetings For April, May

March 26, 1976

Surgical Oncology Planners Develop NCPP research Approaches, Projects

May 24, 1974